HPLC purity verification uses high-performance liquid chromatography to separate the components of a peptide sample, quantitate the target compound as a percentage of total UV-detectable material, and document the impurity profile. HPLC is the industry-standard purity readout on research-peptide certificates of analysis and the foundation of every credible quality claim.
Definition
High-performance liquid chromatography (HPLC) is an analytical separation technique. A small volume of dissolved sample is injected onto a packed chromatographic column under high pressure, the column resolves the components by differential partitioning between the mobile phase and the stationary phase, and a detector at the column outlet (most commonly a UV-visible absorbance detector at peptide-bond wavelengths around 214 nm) records the elution profile as a chromatogram of peaks against time.
For peptide purity verification, reversed-phase HPLC (RP-HPLC) is the dominant mode. The peptide and any sequence variants, deletion peptides, deamidation products, or process-related impurities elute at characteristic retention times set by their hydrophobicity. The percentage purity is calculated by integrating the area under each peak in the chromatogram and dividing the target-peptide peak area by the sum of all peak areas detected within the integration window. The standard reporting convention quotes purity as a percentage at 214 nm (e.g., ≥98% by HPLC at 214 nm) with the chromatogram itself included on the certificate of analysis for direct inspection.
How HPLC purity is reported and verified in peptide supply
A complete peptide purity verification combines HPLC purity quantitation with mass spectrometry for identity confirmation. The HPLC step answers “how much of the sample is the target peak”; the mass spectrometry step answers “is the target peak actually the intended peptide”. The two methods are run on the same batch and reported on the same certificate of analysis. Industry practice for research peptides is a published purity floor (typically ≥98% by HPLC, sometimes ≥99%) with the chromatogram and the mass spectrum both included on the certificate so the buyer can verify the claim against the raw analytical data rather than the vendor’s headline number alone.
The analytical-validation framework for HPLC purity methods is set out in ICH Q2(R1) and the corresponding USP general chapter. For Ronin specifically, every supplied batch is tested by a third-party analytical laboratory by HPLC and mass spectrometry, with the per-batch certificate of analysis available via the lab-results email-gating workflow on the lab results page.
Related terms
- Lyophilized
- Bacteriostatic water
- Mass spectrometry
- Certificate of analysis (COA)
- Reversed-phase HPLC (RP-HPLC)
- Reference standard
Where HPLC purity verification appears in the Ronin workflow
Every Ronin batch ships with a third-party HPLC and mass-spectrometry verified purity certificate. The certificate is available via the email-gating workflow on the lab results page. The Compound specifications accordion on each product page lists the headline purity threshold, and the Quality verification block on each product page summarises the third-party testing chain.
References
- ICH Q2(R1) — Validation of Analytical Procedures: Text and Methodology. International Council for Harmonisation guideline.
- USP <621> Chromatography — general chapter defining system suitability and reporting for chromatographic methods.
- USP <1086> Impurities in Drug Substances and Drug Products — framework for impurity identification, qualification, and reporting thresholds.
Glossary entries describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.